Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4,369 | 4,505 | 5,534 | 6,208 | 5,237 | 5,269 | 6,528 | 6,574 | 6,123 | 6,865 | 7,587 | 8,017 | |
| COGS | 1,474 | 1,469 | 1,612 | 1,586 | 1,471 | 1,583 | 1,697 | 1,790 | 1,691 | 1,836 | 1,976 | 2,240 |
| Gross profit | 2,895 | 3,037 | 3,922 | 4,621 | 3,766 | 3,686 | 4,831 | 4,784 | 4,433 | 5,028 | 5,611 | 5,777 |
| 1,726 | 1,878 | 2,275 | 2,519 | 2,282 | 2,276 | 2,710 | 2,661 | 2,412 | 3,154 | 3,057 | 3,810 | |
| 1,170 | 1,159 | 1,648 | 2,103 | 1,484 | 1,410 | 2,120 | 2,123 | 2,021 | 1,874 | 2,554 | 1,967 | |
| OPM % | 26.8% | 25.7% | 29.8% | 33.9% | 28.3% | 26.8% | 32.5% | 32.3% | 33% | 27.3% | 33.7% | 24.5% |
| Depreciation | 184 | 195 | 205 | 215 | 234 | 229 | 238 | 238 | 302 | 360 | 508 | 555 |
| Interest | 9 | 20 | 35 | 32 | 25 | 32 | 77 | 85 | 101 | 130 | 123 | 156 |
| 53 | 60 | 160 | 63 | 69 | 57 | -139 | 155 | 75 | 27 | -263 | 88 | |
| Profit before tax | 1,030 | 1,004 | 1,567 | 1,919 | 1,293 | 1,206 | 1,667 | 1,955 | 1,693 | 1,411 | 1,659 | 1,344 |
| Tax | 226 | 214 | 321 | 436 | 373 | 180 | 423 | 434 | 454 | 388 | 318 | 354 |
| Tax % | 22% | 21.3% | 20.5% | 22.7% | 28.9% | 14.9% | 25.4% | 22.2% | 26.8% | 27.5% | 19.2% | 26.4% |
| 803 | 790 | 1,246 | 1,483 | 920 | 1,026 | 1,244 | 1,521 | 1,239 | 1,023 | 1,341 | 990 | |
| PAT margin % | 18.4% | 17.5% | 22.5% | 23.9% | 17.6% | 19.5% | 19.1% | 23.1% | 20.2% | 14.9% | 17.7% | 12.4% |
| EPS (₹) | 7.9 | 7.8 | 11.7 | 14.1 | 9.1 | 10.2 | 11.6 | 14.6 | 12.5 | 10.4 | 12.7 | 9.4 |
| Results filing | — | — | — | — | — | — | — | — | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +5.7% | +3.3% | +10.4% | +20.8% | +19.9% | +17% | +18% | +5.9% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Pharmaceuticals | 6,298.1 | 1,245.2 | 39,047.9 | 15,411.4 | 23,636.5 |
| Consumer products | 1,435.9 | 161.3 | 10,457.5 | 4,520 | 5,937.5 |
| +16.9% |
| +30.3% |
| +16.2% |
| +22% |
| PAT YoY % | +52.7% | +25.1% | +247.9% | +30.8% | +14.6% | +29.9% | -0.2% | +2.6% | +34.6% | -0.3% | +7.8% | -34.9% |
| Medical technologies | 283 | -81.7 | 6,240.9 | 6,386 | — |
₹ crore by quarter